The PRECEDE annual meeting brought together over 150 of the world’s top scientists, clinicians, and industry representatives to exchange ideas and develop novel approaches to early detection of pancreatic cancer. Members of the PRECEDE Consortium meet every year to review progress and identify new technology and innovations that can move us towards our collective goal of making pancreatic cancer a treatable disease. View the gallery to experience the conversations and connections that made the day meaningful.
